Advertisement

The Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients with Charcot Foot

  1. Robert Bem, MD, PHD (bemrob{at}yahoo.co.uk)1,
  2. Alexandra Jirkovská, MD, PHD1,
  3. Michal Dubský, MD1,
  4. Vladimira Fejfarová, MD, PHD1,
  5. Marie Buncová, MD, PHD2,
  6. Jelena Skibová1 and
  7. Edward B. Jude, MD, FRCP3
  1. 1 Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
  2. 2 Department of Nuclear Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
  3. 3 Diabetes Centre, Tameside General Hospital, Ashton-Under-Lyne, Lancashire, UK

    Abstract

    Objective: To assess the new quantitative bone scan parameters as markers of Charcot neuroosteoarthropathy (CNO) activity.

    Reasearch Design And Methods: Forty-two patients with acute (n=21) and non-acute (n=21) CNO underwent quantitative bone scanning. Patients with acute CNO were followed for 3-12 months and bone scans were repeated after treatment. New quantitative parameters were assessed and compared with markers of bone turnover and with skin temperature difference (STD).

    Results: Significant correlations between quantitative bone scan parameters and bone turnover markers were observed (all p<0.05). These parameters decreased after treatment of CNO and its reduction to the baseline value correlated with differences of bone turnover markers and STD (all p<0.05).

    Conclusions: Our study suggests that bone scanning can be used not only for diagnosis of CNO, but also for monitoring disease activity by quantitative bone scan parameters.

    Footnotes

      • Received May 26, 2009.
      • Accepted November 14, 2009.

    This Article

    1. Diabetes Care November 23, 2009
    1. All Versions of this Article:
      1. dc09-0950v1
      2. 33/2/348 most recent
    Advertisement